Evidence map›Paper›PMID 25100247›Full record

ArticlePloS one2014

β2-Microglobulin amyloid fibril-induced membrane disruption is enhanced by endosomal lipids and acidic pH.

Sophia C Goodchild, Tania Sheynis, Rebecca Thompson, Kevin W Tipping, Wei-Feng Xue, Neil A Ranson, Paul A Beales, Eric W Hewitt, Sheena E Radford

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Human wild-type and D76N βFASEB bioAdvances · 2023
    Article
  4. Review
  5. Review
  6. Global Proteotoxicity Caused by Human βInternational journal of molecular sciences · 2021
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Structure and Aggregation Mechanisms in Amyloids.Molecules (Basel, Switzerland) · 2020
    Review
  12. Review
  13. Extracellular matrix components modulate different stages in βThe Journal of biological chemistry · 2019
    Article
  14. A new era for understanding amyloid structures and disease.Nature reviews. Molecular cell biology · 2018
    Review
  15. The structure of a βNature communications · 2018
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Sophia C GoodchildAstbury Centre for Structural Molecular Biology and School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom.
Tania SheynisAstbury Centre for Structural Molecular Biology and School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom.
Rebecca ThompsonAstbury Centre for Structural Molecular Biology and School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom.
Kevin W TippingAstbury Centre for Structural Molecular Biology and School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom.
Wei-Feng XueAstbury Centre for Structural Molecular Biology and School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom.
Neil A RansonAstbury Centre for Structural Molecular Biology and School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom.
Paul A BealesAstbury Centre for Structural Molecular Biology and School of Chemistry, University of Leeds, Leeds, United Kingdom.
Eric W HewittAstbury Centre for Structural Molecular Biology and School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom.
Sheena E RadfordAstbury Centre for Structural Molecular Biology and School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom.
University of Leeds · GBInstitute of Structural and Molecular Biology · GB

Funding

European Research Council 322408Wellcome Trust 080707/z/06/zWellcome Trust 092896Wellcome Trust 092896 MAWellcome Trust 096685/z/11/z
6 · The paper itself

Abstract

Although the molecular mechanisms underlying the pathology of amyloidoses are not well understood, the interaction between amyloid proteins and cell membranes is thought to play a role in several amyloid diseases. Amyloid fibrils of β2-microglobulin (β2m), associated with dialysis-related amyloidosis (DRA), have been shown to cause disruption of anionic lipid bilayers in vitro. However, the effect of lipid composition and the chemical environment in which β2m-lipid interactions occur have not been investigated previously. Here we examine membrane damage resulting from the interaction of β2m monomers and fibrils with lipid bilayers. Using dye release, tryptophan fluorescence quenching and fluorescence confocal microscopy assays we investigate the effect of anionic lipid composition and pH on the susceptibility of liposomes to fibril-induced membrane damage. We show that β2m fibril-induced membrane disruption is modulated by anionic lipid composition and is enhanced by acidic pH. Most strikingly, the greatest degree of membrane disruption is observed for liposomes containing bis(monoacylglycero)phosphate (BMP) at acidic pH, conditions likely to reflect those encountered in the endocytic pathway. The results suggest that the interaction between β2m fibrils and membranes of endosomal origin may play a role in the molecular mechanism of β2m amyloid-associated osteoarticular tissue destruction in DRA.

Indexed as

AmyloidAmyloidosisbeta 2-MicroglobulinEndosomesHumansHydrogen-Ion ConcentrationIntracellular MembranesMembranes, ArtificialRenal DialysisAmyloidbeta 2-MicroglobulinMembranes, Artificial

Identifiers

PMID25100247
PMCPMC4123989
OpenAlexW1990695557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.